CFDE Data Portal | Search GPD2

	Label	Description
	GPD2 Gene (Entity type)	ENSG00000115159 - glycerol-3-phosphate dehydrogenase 2
	GPD2 associations Collection (Entity type)	Associations for GPD2_associations
	GPD2 associations.tsv File (Entity type)	A file from IDG as part of the Harmonizome project
	GPD2 YEAST Protein (Entity type)	Glycerol-3-phosphate dehydrogenase [NAD(+)] 2, mitochondrial (precursor)
	GSE216043 7 V 9 CISPLATIN HUMAN DN Gene Set (Entity type)	A Gene Set from LINCS
	GSE240439 decitabine 1 v 2 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE216273,GSE216292 14 V 6 PALBOCICLIB HUMAN DN Gene Set (Entity type)	A Gene Set from LINCS
	GSE225869 1 V 0 TEMOZOLOMIDE HUMAN DN Gene Set (Entity type)	A Gene Set from LINCS
	GSE150244 TRIM8 knockout 3 v 0 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE135350 2 V 4 DEXAMETHASONE HUMAN UP Gene Set (Entity type)	A Gene Set from LINCS

GPD2

ENSG00000115159 - glycerol-3-phosphate dehydrogenase 2

GPD2 associations

Associations for GPD2_associations

GPD2 associations.tsv

A file from IDG as part of the Harmonizome project

GPD2 YEAST

Glycerol-3-phosphate dehydrogenase [NAD(+)] 2, mitochondrial (precursor)

GSE216043 7 V 9 CISPLATIN HUMAN DN

A Gene Set from LINCS

GSE240439 decitabine 1 v 2 human up

A Gene Set from LINCS

GSE216273,GSE216292 14 V 6 PALBOCICLIB HUMAN DN

A Gene Set from LINCS

GSE225869 1 V 0 TEMOZOLOMIDE HUMAN DN

A Gene Set from LINCS

GSE150244 TRIM8 knockout 3 v 0 human dn

A Gene Set from LINCS

GSE135350 2 V 4 DEXAMETHASONE HUMAN UP

A Gene Set from LINCS

DISPLAY PER PAGE

@CFDE Workbench 2026

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2026

This repository is under review for potential modification in compliance with Administration directives.